BioSpace News Archive

Syngene announced its G:BOX Chemi XRQ multi-application imager is being used in the School of Biochemistry at the University of Bristol.

It’s less than a week before Lab Innovations 2017 begins, and preparations are in full swing as the NEC Birmingham gets ready to open its doors and welcome over 130 exhibitors showcasing the latest analytical, biotech and laboratory products.

Dendreon Pharmaceuticals today announced several key leadership appointments to further the company’s continued growth and expansion.

A conference call will be held at 4:30pm ET on Monday November 6, 2017 to discuss the 3rd quarter 2017 financial results and business update.

ADM Tronics Unlimited announced today that its client Origin has today announced positive interim results from its “GENESIS” US-based dose-ranging Phase IIb trial in the treatment of Diabetic Foot Ulcers utilizing a proprietary plasma technology.

The Company will host a conference call and webcast at 8:30 a.m. ET to review financial and operational results for the quarter ended September 30, 2017 and provide a company update.

Agendia announces new data published today in JAMA Oncology that demonstrate the benefits of the MammaPrint 70-Gene Breast Cancer Risk-of-Recurrence test to significantly change treatment management decisions for patients who had previously received an ‘intermediate’ risk result according to the 21-gene assay.

Oncoquest today announced the signing of a collaborative agreement with TESARO to conduct a proof-of-concept clinical trial evaluating the combination of oregovomab with ZEJULA (niraparib) in the recurrent ovarian cancer setting.

The first patient in Japan was treated with the Impella 5.0 heart pump after suffering from acute heart failure.

Up to 30 patients will be recruited in total from the United States and Israeli trial sites.